Inheritance + Innovation + Development: The "Co-development" Path of Hakka Medicine and Traditional Chinese Medicine

HONG KONG, Dec. 9, 2025 /PRNewswire/ — From November 23 to 25,…

Innovent Announces PECONDLE® (Picankibart Injection) Phase 3 Study (CLEAR-2) Meets Endpoints, Delivering Superior Long-Term Management Solution for Moderate-to-Severe Psoriasis

SAN FRANCISCO and SUZHOU, China, Dec. 9, 2025 /PRNewswire/ — Innovent Biologics,…

Kia PV5 Cargo Achieves Maximum Five-Star Rating in 2025 Euro NCAP Commercial Van Safety Assessment

Kia PV5 Cargo earns the top five-star rating in the 2025 Euro…

ADFW Opens with Spotlight on Abu Dhabi's Global Ambition and Major Humanitarian Pledge

ABU DHABI, UAE, Dec. 9, 2025 /PRNewswire/ — Abu Dhabi Finance Week…

From a Simple Idea to a Global Standard: EV Blocks Founder Wins Global Entrepreneur of the Year 2025

What started as a frustration on site has become a global product. …

With Child Deaths Projected to Rise for the First Time in a Century, Gates Foundation and Mohamed Bin Zayed Foundation for Humanity Urge Action as World Faces Critical Turning Point

 At Goalkeepers Abu Dhabi, global leaders outline a path to improve and…

EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide

PROVIDENCE, R.I., Dec. 9, 2025 /PRNewswire/ — EpiVax, Inc., with U.S. Food and…

Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

In addition, the expansive elacestrant clinical development program updates reinforce its potential as…